Your browser doesn't support javascript.
loading
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.
Thomson, Ashlee J; Rehn, Jacqueline A; Heatley, Susan L; Eadie, Laura N; Page, Elyse C; Schutz, Caitlin; McClure, Barbara J; Sutton, Rosemary; Dalla-Pozza, Luciano; Moore, Andrew S; Greenwood, Matthew; Kotecha, Rishi S; Fong, Chun Y; Yong, Agnes S M; Yeung, David T; Breen, James; White, Deborah L.
Afiliación
  • Thomson AJ; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Rehn JA; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Heatley SL; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Eadie LN; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Page EC; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Schutz C; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • McClure BJ; Australian and New Zealand Children's Oncology Group (ANZCHOG), Clayton, VIC 3168, Australia.
  • Sutton R; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Dalla-Pozza L; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Moore AS; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Greenwood M; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Kotecha RS; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Fong CY; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Yong ASM; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
  • Yeung DT; Molecular Diagnostics, Children's Cancer Institute, Kensington, NSW 2750, Australia.
  • Breen J; The Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
  • White DL; Oncology Service, Children's Health Queensland Hospital and Health Service, Brisbane, QLD 4101, Australia.
Cancers (Basel) ; 15(19)2023 Sep 26.
Article en En | MEDLINE | ID: mdl-37835427
ABSTRACT
B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by diverse genomic alterations, the most frequent being gene fusions detected via transcriptomic analysis (mRNA-seq). Due to its hypervariable nature, gene fusions involving the Immunoglobulin Heavy Chain (IGH) locus can be difficult to detect with standard gene fusion calling algorithms and significant computational resources and analysis times are required. We aimed to optimize a gene fusion calling workflow to achieve best-case sensitivity for IGH gene fusion detection. Using Nextflow, we developed a simplified workflow containing the algorithms FusionCatcher, Arriba, and STAR-Fusion. We analysed samples from 35 patients harbouring IGH fusions (IGHCRLF2 n = 17, IGHDUX4 n = 15, IGHEPOR n = 3) and assessed the detection rates for each caller, before optimizing the parameters to enhance sensitivity for IGH fusions. Initial results showed that FusionCatcher and Arriba outperformed STAR-Fusion (85-89% vs. 29% of IGH fusions reported). We found that extensive filtering in STAR-Fusion hindered IGH reporting. By adjusting specific filtering steps (e.g., read support, fusion fragments per million total reads), we achieved a 94% reporting rate for IGH fusions with STAR-Fusion. This analysis highlights the importance of filtering optimization for IGH gene fusion events, offering alternative workflows for difficult-to-detect high-risk B-ALL subtypes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Australia